BioSpace News Archive

Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company, is pleased to announce that NP-120, its repurposed lead candidate for the treatment of idiopathic pulmonary fibrosis, showed dramatic superiority over Gefapixant, Merck’s lead phase 3 trial drug, in a well accepted acute cough in-vivo animal study.

First Databank, Inc. announced that its medication adherence solution, Meducation, received the first-ever Cerner Open Developer Experience Program Member Adoption Award during this year’s Cerner Health Conference in Kansas City.

In 2018, there were 2,782 organ transplant procedures performed in Canada, according to the latest information published by the Canadian Institute for Health Information.

Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has received approval for the use of OxC-beta™ Livestock in Broilers and Swine in Malaysia

Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced poster and oral presentations at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT) in Washington, D.C.

Meeting Highlights Include New Phase 3 Data for EPIDIOLEX in Tuberous Sclerosis Complex and Award-Winning Virtual Reality Experience

Vedanta Biosciences eligible for an additional $3.5 million upon completion of certain milestones

Applied DNA Sciences, Inc., announced it plans to release financial results for its fiscal 2019 fourth quarter ended September 30, 2019 after market close on Thursday, December 12, 2019.

All 27 States Have Provided Approvals of Centene’s Control of WellCare Domestic Insurers

Pivot Pharmaceuticals Inc.announced its corporate name change to BetterLife Pharma Inc.